Shisi Pharmaceutical Group (02005) obtained drug production registration approval for acetylcysteine injection (25ml:5g)

Zhitong Finance App News, Shisi Pharmaceutical Group (02005) announced that the group has obtained drug production registration approval from the China National Drug Administration for acetylcysteine injection (25ml: 5g). It is a category 3 chemical drug. It is considered to have passed the consistency evaluation, and is the third domestic company to be approved. Acetylcysteine injections are mainly used to detoxify acute acetaminophen poisoning and prevent or reduce liver damage caused by excessive doses.

Furthermore, the group has obtained drug production registration approval from the State Drug Administration for compound sodium acetate Ringer injection (500ml), which is a Class 3 chemical drug, and is deemed to have passed the consistency evaluation. Compound sodium acetate Ringer injection is mainly used to supplement extracellular fluid and correct metabolic acidosis when circulating blood volume and intertissue fluid decrease.